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Objective: To evaluate the effectiveness of Internet and telephone-based 
telemedicine system managing on patients’ glycemic index, blood pres-
sure, and lipid level control in underserved subjects with type 2 diabetes 
in Western China. Research designs and methods: In a 3 years, ran-
domized, controlled, single-blind, parallel-group treat-to-target study, 
412 subjects with type 2 diabetes were randomized to telemedicine (Tel; 
n =208) group and usual care (control; n =204) group. We evaluated the 
effects of the intervention on blood sugar, blood pressure, and lipid levels 
at 1, 2, 3 years point, and investigated the cause of the loss during fol-
low-up by phone call. Results: Intra-group comparison: in the Tel group, 
the FBS, 2HPG, HbA1c, and SBP at 1, 2, 3 years and DBP, TC, TG, BMI 
at 2, 3 years were significantly decreased compared with baseline level 
(P<0.05). Moreover, the Tel group had an obvious better control of their 
HbA1c  at 2 and 3 years and 2HPG  at 3 years of follow-up respectively 
compared with the outcomes at 1 year (P<0.05).Inter-group comparison: 
the FBS, 2HPG, and HbA1c of Tel group decreased significantly from 
the baseline to the 1 year more than those of control group (P<0.05 or 
P<0.01 ). In this analysis, all clinical measures of Tel group had a sig-
nificant downward compared with the outcomes of Control group  at 2 
years, the FBS, HbA1c and BMI (P<0.001), the 2HPG and SBP (P<0.01) 
and DBP, TC, and TG (P<0.05) were statistically significant respectively. 
Logistic regression analysis showed that the subject loss during follow-up 
was associated with worse diabetes management (OR=3.842), low in-
come (OR=3.201), low education level (OR=0.923), and greater distance 
to the hospital (OR=0.921).Conclusions: The study results indicated that 
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1. Introduction
The increased incidence of type 2 diabetes (T2DM) and associated increases in mortality are import-ant challenges facing the world [1]. Diabetes can 
damage the heart, blood vessels, eyes, kidneys and nerves, 
leading to foot amputation and related deaths. The World 
Health Organization predicts that diabetes-related mor-
tality will double between 2005 and 2030 [2]. In China, 
the study found that the overall prevalence of diabetes in 
adults is estimated at 11.6%; of these, 12.1% of men and 
11.0% of women [3]. The pre-diabetes prevalence rate of 
Chinese adults was 50.1%: 52.1% for men and 48.1% for 
women. It is worth noting that the pre-diabetes prevalence 
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rate of rural residents is slightly higher than that of urban 
residents, especially men. In addition, pre-diabetes are 
more prevalent in economically underdeveloped areas and 
overweight and obese people. These studies suggest that 
the incidence of diabetes may reach alert levels among 
Chinese adults, and diabetes can lead to major epidemics 
of related complications, including cardiovascular disease, 
stroke and chronic kidney disease. If the Chinese govern-
ment does not adopt effective state interventions, diabetes 
will be a serious problem in the near future. [3]. 
Diabetes patient education and interventions can im-
prove patients’ self-care activities, maintain metabolic 
stability, improve quality of life, and prevent or delay the 
development of complications [4]. In a systematic review 
of 41 studies involving 48,000 patients, the researchers 
described the effectiveness of professional guidance, orga-
nizational transformation, and patient-centered interven-
tions for health professionals [5]. However, most of these 
studies have been selected in cities with good health care. 
In contrast, many patients, particularly the underserved do 
not attain these recommended levels of care, due to pov-
erty, economic backwardness, and poor insurance. A lot of 
people with uncontrolled Type 2 diabetes do not achieve 
recommended targets including blood sugar, blood pres-
sure, and lipid levels. Presently, diabetes management is 
seldom reported in underserved subjects of the econom-
ically underdeveloped area. We, therefore, implemented 
a telephone and internet-based system for offering pro-
fessional care management for an underserved type 2 di-
abetes patients with or without medical insurance in poor 
areas of Western China. 
2. Research Design and Methods
2.1. Patients
The study protocol was approved by an independent 
ethics committee at each center, based on the Helsinki 
Declaration and Clinical Practice Guidelines. All volun-
teers provided written consent before the study [6]. We 
conducted a randomized, controlled, single-blinded, par-
alleled-group study to test the hypothesis that an internet 
and telephone-based communication systems of diabetes 
care will allow more patients to reach individualized tar-
get blood glucose level when compared with usual care. 
Each patient obtained an ID using a computer-based ran-
dom number generator on internet system, and then had 
adequate allocation concealment using serially numbered 
sealed opaque envelopes. Statistical outcomes were inter-
preted blindly by a statistician.  There are five basic ele-
ments in research design: education and behavioral guid-
ance, development of treatment plans, care management, 
team care methods, and physician leadership. Develop 
all the details of the study, including clinic staff and lead-
ership training, patient process protocols and a detailed 
description of the budget.
2.2. Inclusion and Exclusion Criteria
Population of people from ten counties and districts of re-
mote areas in the West of China were studied. Volunteers 
were recruited from county-level hospitals, community 
activity centers, medical affiliated hospitals, and medical 
centers. The inclusion criteria are: a. Diagnose patients 
with T2DM, b. Adults between the ages of 20 and 65, c. 
Ability to live independently, d. Ability to complete the 
questionnaire independently, e. Informed and agreed to 
participate in the study and sign an informed consent 
form.. The exclusion criteria were: a. patients who were 
pregnant, planning a pregnancy, or currently lactating 
during the study, b. patients with severe diabetic compli-
cations and c. patients with liver and kidney dysfunction. 
Eventually the eligible 412 subjects were randomly divid-
ed into two groups based on telemedicine: telemedicine 
(Tel) group with 208 people and control group with 204 
people (usual care).  
2.3. Organization Training
Patients in telemedicine management (telephone group) 
receive diabetes-related care management, including 
diabetes education, self-management, and medication 
guidance, which consists of nurse administrators and 
doctors at research centers. In addition, telemedicine sub-
jects have received training in telemedicine use. Control 
subjects (control group) were provided with data from 
their baseline assessment and instructed to contact their 
primary caregiver for further care. No further intervention 
was provided for the control subjectsDue to local funding 
needs and the willingness of employees to participate in 
diabetes quality improvement training, intervention clinics 
and follow-ups were purposefully selected. All costs from 
baseline to final follow-up of biochemical and serological 
tests for the eligible 412 subjects relied on the local fund-
ing. The cost of drug and other tests from baseline to final 
follow-up relied on medical insurance or fee-paying.
2.4. Follow-up
412 patients were followed up, each telemedicine patient 
was followed up once every three months by the profes-
sional nurse and once every six months by the profes-
sional physician alternately, excluding the exit patients. 
While the nurse called patient via telemedicine system to 
provide diabetic care, the physician gave instruction on 
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the treatment,  the nurse ask physician for help. Overview 
of care for people with diabetes, such as medication use, 
diet planning, exercise, blood glucose monitoring, dietary 
restrictions, medication adherence, foot care and smoking 
cessation[7]. Diabetes and quality of life, such as diabetes 
condition control, treatment satisfaction, social life and 
sexual function[8]. Subsequently each patient was seen at a 
follow-up visit at least once every 1 year and the indicator 
for further observation was completed at the research cen-
ter. The clinical goals of the telemedicine program include 
raising hemoglobin A1c levels to 7.0%, blood pressure 
(BP) to below 140/90 mmHg, and triglyceride (TG) levels 
to below 150 mg/dL. When the patient’s hemoglobin A1c, 
blood pressure and TG levels are higher than the clinical 
target, the doctor will increase the patient’s medication 
regimen, including current medication metrology adjust-
ments and new oral medications or insulin.
2.5. Data Entry
Each patient receives an ID from a random number gener-
ator on the Internet. The staff then collected the patient’s 
experimental data using standard procedures at base-
line, 1 year, 2 years, and 3 years. Includes demographic 
characteristics such as age, gender, insurance, duration 
of diabetes, height, weight (calculated BMI), and blood 
pressure. Blood samples were obtained by venipuncture 
and fasting blood glucose was measured using standard 
laboratory procedures, hemoglobin A1c, total cholesterol, 
triglycerides, low density lipoprotein (LDL), high density 
lipoprotein (HDL), aspartate aminotransferase ( AST), ala-
nine aminotransferase (ALT) and creatinine. 2h-post-meal 
plasma glucose (2hPG) was performed after the meal.
2.6. Statistical Analysis
The analysis was performed by SAS 8.1 (SAS Institute 
Inc., Cary, NC) and GraphPad Prism 5 (GraphPad Soft-
ware, Inc., San Diego, USA). Results were presented as 
mean ± SD. Chi-square tests were adopted for comparing 
differences among the groups. Logistic regression was 
used to estimate the odds ratio (OR) and 95% confidence 
interval (CI) of the reason for the loss during follow-up , 
including diabetes management，income level，educa-
tion level，and the distance to the hospital. A P value of 
less than 0.05 was considered statistically significant.
The study may have lost follow-up, and if some ran-
dom participants are not within the scope of the analysis, 
the estimated intervention may be biased. This kind of 
missing imbalance between groups may indicate bias. 
Intent-to-treat (ITT) analysis aims to randomly include all 
participants in the trial, regardless of what happens next. 
In this study, the “last observation” was implemented to 
assume that no changes occurred; ITT and each protocol 
(PP) analysis were performed.
3. Results 
3.1. Clinical Outcomes
The study was conducted over a 3-year period and we 
recruited 450 subjects. Out of the total number of the 
subject recruited, 26 declined to participate in the study 
after screening process and 12 did not complete screen-
ing process. Figure 1 showed a flow diagram of the re-
cruiting process. The sugar, fat, blood pressure and BMI 
metabolic parameters of four groups were observed at 1, 
2, and 3 years. Because of the loss in number of control 
group exceeded 15%, it was a failure comparison in 3 
years.
Figure 1. Subject flow diagram. The number of patients 
at baseline, the frequency of follow-up visits, reasons for 
withdrawal,number of patients completing the study and 
the number of ITT.  ITT, intention to treat analysis.
As shown in Table 1, there were no statistical signifi-
cant differences in demographic characteristics or mean 
clinical parameters at baseline between patients in the 
intervention and control practices. Sixty-one percent were 
male, more than 77% had low family incomes at or near 
the poverty level, and 25% completed high school. Dia-
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Table 1. Baseline characteristics of participants by group
Characteristics Tel group (n=208) Control group(n=204) P




Diabetes duration, years 6.1 (5.0) 6.0 (4.9) 0.7612
Height, cm 165.0 (11.2) 168.0 (10.8) 0.0536
Weight, kg 70.6 (10.5) 71.0 (10.7) 0.2906
BMI, kg/ m2 25.1 (2.5) 25.0 (2.6) 0.4261
Systolic blood pressure, mmHg 132.8 (17.2) 130.9 (19.0) 0.1833
Diastolic blood pressure, mmHg 79.0 (8.5) 78.3(9.0) 0.8356
Fasting plasma glucose, mg/dL 146.3 (38.4) 145.0 (39.2) 0.9244
Postprandial 2-h glucose, mg/dL 230.5 (66.6) 227.8 (67.4) 0.7578
A1C, % 8.4 (1.5) 8.4 (1.6) 0.5093
Total cholesterol, mg/dL 165.6 (37.7) 163.5(39.2) 0.2832
Triglyceride, mg/dL 145.2 (58.0) 146.7(57.1) 0.2870
HDL cholesterol, mg/dL 51.4 (10.5) 51.1 (9.7) 0.2204
LDL cholesterol, mg/dL 107.5(25.5) 106.7(23.9) 0.5503
Aspartate aminotransferase, IU/L 22.6 (9.1) 22.3 (8.5) 0.2934
Alanine aminotransferase, IU/L 25.7 (13.1) 25.3 (11.9) 0.7761
Serun creatinine, mg/dL 1.16 (0.25) 1.13 (0.20) 0.1228
Medication for glucose control
None, n (%) 13(6.3) 13(6.4) 0.7993
Sulfonylurea, n (%) 81(38.9) 77(37.7) 0.7097
Metformin, n (%) 100(48.1) 99(48.5) 0.5037
Thiazolidinedione, n (%) 18(8.7) 19(9.3) 0.3580
a-Glucosidase inhibitor, n (%) 41(19.7) 37(18.1) 0.6306
Dipeptidyl peptidase 4, n (%) 11(5.3) 12(5.9) 0.7921
Insulin, n (%) 22(10.6) 21(10.3) 0.8737
Education level 0.9250
Primary school, n (%) 59(28.4) 65(32.0)
Junior high school, n (%) 95(45.7) 94 (46.2)
High school, n (%) 54(25.9) 45(21.8)
Income 0.9791
low income, n (%) 162 (77.8) 165 (80.8)
medium income, n (%) 38(18.5) 31(15.30)
high income, n (%) 8(3.7) 8(3.9)
Note: Data are presented as mean (SD) or number of participants (%).  
DOI: https://doi.org/10.30564/jer.v1i1.671
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Anthropometric and biochemical parameters after 1, 2, 
and 3 years of follow-up are summarized in Table 2.
3.2. Intra-group Comparison
In the Tel group, FBS, 2HPG, HbA1c, and SBP (Figure 
Table 2. Change of clinical measures at 1, 2 and 3 years follow up by group
Clinical  Parameters Tel group Control group
FPG (mg/dL) 0 years 146.3 (38.4) (n=208) 145.0 (39.2) (n=204)
1 years 138.1 (34.0) (n=208) 146.1 (38.5) (n=204)
2 years 133.1 (27.0) (n=205) /133.2 (27.1) (n=208,ITT) 147.3(39.0) (n=190) /147.0(38.9)(n=204,ITT)
3 years 132.3(26.9) (n=201) /132.5 (26.8) (n=208,ITT) - (n=163)
2HPG(mg/dL) 0 years 230.5 (66.6) (n=208) 227.8 (67.4) (n=204)
1 years 216.1 (53.0)(n=208) 230.1 (68.6) (n=204)
2 years 208.9(45.5) (n=205) /202.0(43.6) (n=208,ITT)
230.0 (69.5) (n=190) /229.2(69.5)
(n=204,ITT)
3 years 202.2(41.2) (n=201) /203.3(41.6) (n=208,ITT) - (n=163)
A1C (%)  0 years 8.4 (1.5) (n=208) 8.4 (1.6) (n=204)
1 years 8.0 (1.0) (n=208) 8.4(1.5) (n=204)
2 years 7.6 (0.9) (n=205) /7.7 (0.9) (n=208,ITT) 8.4(1.6) (n=190) /8.5(1.5) (n=207,ITT)
3 years 7.5 (0.8) (n=201) /7.6 (0.8) (n=208,ITT) - (n=163)
SBP (mmHg) 0 years 132.8 (17.2) (n=208) 130.9 (19.0) (n=204)
1 years 128.8 (17.0) (n=208) 131.1 (19.8) (n=204)
2 years 126.3 (16.4) (n=205) /126.7 (16.3) (n=208,ITT) 131.0 (19.6) (n=190) /131.1(20.2)(n=204,ITT)
3 years 125.1(15.6) (n=201) /125.2(15.7) (n=208,ITT) - (n=163)
DBP (mmHg) 0 years 79.0 (8.5) (n=208) 78.3(9.0) (n=204)
1 years 78.4 (8.0) (n=208) 78.1 (9.8) (n=204)
2 years 76.1 (7.6) (n=205) /76.3 (7.6) (n=208,ITT) 78.3 (9.9) (n=190)/78.2 (9.8) (n=204,ITT)
3 years 75.3(7.6) (n=201) /75.5(7.6) (n=208,ITT) - (n=163)
TC(mg/dL) 0 years 165.6 (37.7) (n=208) 163.5(39.2) (n=204)
1 years 162.1 (35.0) (n=208) 164.1 (39.0) (n=204)
2 years 156.7 (30.5) (n=205) /156.9 (30.6) (n=208,ITT) 163.7 (39.1) (n=190) /163.8(39.1)(n=204,ITT)
3 years 155.3(29.9) (n=201) /156.0(29.8) (n=208,ITT) - (n=163)
TG (mg/dL) 0 years 145.2 (58.0) (n=208) 146.7(57.1) (n=204)
1 years 138.5 (52.4) (n=208) 147.1 (57.8) (n=204)
2 years 132.7 (45.5) (n=205) /133.0(45.6) (n=81,ITT) 145.0 (56.9) (n=190) /145.5(57.0)(n=204,ITT)
3 years 130.3(43.0) (n=201) /130.5(43.1) (n=81,ITT) - (n=163)
BMI (kg/m2) 0 years 25.1 (2.5) (n=208) 25.0 (2.6) (n=204)
1 years 24.7 (2.6) (n=208) 25.1 (2.5) (n=204)
2 years 24.3(2.5) (n=205) /24.2 (2.5) (n=208,ITT) 25.2(2.5) (n=190) /25.2(2.4) (n=204,ITT)
3 years 23.9(2.5) (n=201) /24.0(2.5) (n=208,ITT) - (n=163)
Results are expressed as the mean ± SD. - no statistical data (Loss of follow-up rate was more than 20%). ITT: intention to treat
Analysis (last observation carried forward). FPG , fasting plasma glucose;2HPG , postprandial 2-h glucose; HbA1c, hemoglobin A1c;
SBP , systolic blood pressure; DBP , diastolic blood pressure; TC, total cholesterol; TG, triglyceride; BMI, body mass index.
2 A, B, C, and D)  decreased significantly at 1, 2, and 
3 years of follow-up，and DBP, TC, TG, BMI (Figure 
2E,F,G, and H)  also reduced significantly  at 2 and 3 
years compared with baseline level  (P<0.05). More-
over, the Tel group had an obvious better control of their 
DOI: https://doi.org/10.30564/jer.v1i1.671
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HbA1c (Figure2C) at 2 and 3 years and 2HPG (Figure2B) 
at 3 years of follow-up respectively compared with the 
outcomes at 1 year (P<0.05).
In addition, the FBS, 2HPG, HbA1c, SBP, DBP, TC, 
TG, and BMI (Figure2A,B,C,D,E,F,G, and H) of Control 
group  had a slight upward trend  from baseline to 2 years, 
however, this was not statistically significant (P>0.05). 
All ITT and PP analysis revealed similar results in Fig-
ure 2 (Intention to treat -last observation carried forward 
data set).
Figure 2. Intra-group comparison of different follow-up 
times
Note: A: FPG levels of four groups at different follow-up times; B: 
2HPG levels of four groups at different follow-up times; C: HbA1c 
levels of four groups at different follow-up times; D: SBP levels of four 
groups at different follow-up times; E: DBP levels of four groups at 
different follow-up times; F: TC levels of four groups at different fol-
low-up times; G: TG levels of four groups at different follow-up times; H: 
BMI levels of four groups at different follow-up times. A(ITT), B(ITT), 
C(ITT), D(ITT), E(ITT), F(ITT), G(ITT), and H(ITT): Corresponding 
index levels of four groups at different follow-up times by ITT. ITT-
LOCF: intention to treat analysis-last observation carried forward. Re-
sults ara expressed as the mean ± SD. ＊ P<0.05, **P<0.01, ***P<0.001 
for comparisons between conditions.
3.3. Inter-group Comparison
As shown in Figure3, the FBS, 2HPG, and HbA1c 
(Figure 3A,B, and C) of Tel group decreased signifi-
cantly from the baseline to the 1 year more than those of 
control group (P<0.05 or P<0.01 ). In this analysis, all 
clinical measures (Figure3A,B,C,D,E,F,G, and H) of Tel 
group had a significant downward compared with the out-
comes of Control group  at 2 years, the FBS, HbA1c and 
BMI (Figure 3A, C and H, P<0.001), the 2HPG and SBP 
(Figure 3B and D, P<0.01) and DBP, TC, and TG (Figure 
3E, F and G, P<0.05) of the Tel group decreased more 
than those of the control group at 2 years, and it were sta-
tistically significant respectively. 
All ITT and PP analysis revealed similar results in Fig-
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Figure 3. Inter-group comparison of same follow-up 
times 
Note: A: FPG levels of four groups at same follow-up times; B: 2HPG 
levels of four groups at same follow-up times; C: HbA1c levels of four 
groups at same follow-up times; D: SBP levels of four groups at same 
follow-up times; E: DBP levels of four groups at same follow-up times; 
F: TC levels of four groups at same follow-up times; G: TG levels of 
four groups at same follow-up times; H: BMI levels of four groups at 
same follow-up times. A(ITT), B(ITT), C(ITT), D(ITT), E(ITT), F(ITT), 
G(ITT), and H(ITT): Corresponding index levels of four groups at same 
follow-up times by ITT. ITT-LOCF: intention to treat analysis-last ob-
servation carried forward. Results ara expressed as the mean ± SD. ＊
P<0.05, **P<0.01, ***P<0.001 for comparisons between conditions.
3.4. Logistic Regression Results
The results of the logistic regression model are given in 
Table 3, which examines the changes from baseline to fi-
nal follow-up and the probability of loss. In this analysis, 
the reason for the loss in follow-up was associated with 
worse diabetes management (OR=3.842), low income 
(OR=3.201), low education level (OR=0.923), and greater 
distance to the hospital (OR=0.921).








agement 1.171 3.842 1.741 1.957 0.009
Low income 1.163 3.201 1.074 9.533 0.037
Education level –0.079 0.923 0.875 0.977 0.006
The distance to the 
hospital –0.083 0.921 1.18 1.50 0.001
Notes: The reason of the lost to follow-up N =48.
4. Discussion 
This study is a 3-year RCT that examined a telephone 
and Internet- based diabetes education intervention for 
diabetes control in a underserved population of Western 
China. Studies have shown that there are significant barri-
ers to achieving good care and good clinical outcomes in 
low-income patients[9, 10]. Parchman et al[11]and Stange[12] 
how primary care physicians are struggling to cope with 
competitive demands when attempting to address elevat-
ed levels of hemoglobin A1c. Our redesign studies have 
shown that diabetes care can be effectively managed even 
in resource-constrained settings.. Because the use of cell 
phone is ubiquitous, most of the subjects preferred it as a 
means of communication. Each telemedicine patient was 
followed up once every three months by the professional 
nurse and once every six months by the professional phy-
sician alternately, excluding the exit patients. The nurse 
provided diabetic care, the physician gave instruction 
on the treatment by telemedicine system. Bray et al. For 
African-American patients who have established diabetes 
interventions, they are provided with professional care 
strategies that can ideally control blood glucose based on 
rural primary care service charges[13]. Our research shows 
that chronic diabetes management can be done through 
a professional team and long-term follow-up. In this 
study, we found that redesigning diabetes care to combine 
professional care management resulted in significant im-
provements in blood sugar, blood lipids, and blood pres-
sure. These findings were consistent with those of Johans-
son et al[14, 15] and Glazier et al[16]. A recent study showed 
that diabetes and its complications in patients with type 2 
diabetes in Taiwan have a combined effect on antidiabetic 
drugs, lifestyle adjustments, and social and psychological 
support, as well as diabetes education, compared with a 
12.5% drop in HbA1c levels in the control group. The 
group fell by 26.7%. This indicates the significant role of 
education and related care in patients with type 2 diabetes 
[17].  However, these studies did not mention further con-
cern about the reason for the loss in follow-up.
The analysis comparing intervention group to control 
group patients showed striking differences in response. 
The telemedicine management can decreased significant-
ly blood sugar, blood pressure and blood lipid compared 
with control group. The results demonstrated that the tele-
medicine management was effective in glycemic index, 
blood pressure, and lipid level control in underserved sub-
jects with type 2 diabetes in Western China. The results of 
the study are consistent with the benefits of telemedicine, 
especially among Hispanic Americans, which have the 
dual qualifications of Medicare and Medicaid, so drug 
DOI: https://doi.org/10.30564/jer.v1i1.671
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costs should not be a problem compared to other popu-
lations [18]. However, the Austrian disease management 
plan implemented through statutory health insurance can 
improve the quality of the process and increase weight, 
but it does not significantly improve the metabolic control 
of patients with type 2 diabetes [19]. The reason for oppo-
site result could be some risk of bias remains. we tried 
to achieve a study design free of bias, and worked out a 
randomized, controlled, single-blind, parallel-group treat-
to-target study. Meanwhile, perfect diabetes management 
was a prerequisite for good quality health care delivery, 
and it could enable more diabetic patients to obtain blood 
sugar, blood pressure, and blood lipids to standard [20]. 
Ngo-Metzger et al. found that there is an economic burden 
for the treatment of diabetes, and because of cost reasons, 
patients are likely to not adhere to medication. Poor drug 
compliance is directly related to poor control of diabetes, 
such as an increase in HbA1c. However, having health in-
surance does reduce the economic pressure on health care 
[21]. Therefore, the results of telemedicine management 
could be more reliable.
In this study, BMI was significantly lower at 2 years 
than at baseline level in the Tel group, and it was statis-
tically significant(P<0.05).  In addition, the BMI of Tel 
group decreased more than those of control group at 2 
years (P<0.05). These findings were consistent with those 
of Mohamed et al [22] and Delahanty et al [23]. The Ameri-
can Association of Diabetes Educators recommends seven 
self-care behaviors as new examples of diabetes education, 
including healthy eating, physical exercise, monitoring, 
adherence to drugs, problem solving, mitigation and risk 
reduction [17]. The subjects of Tel group showed weight 
loss through healthy eating and physical activity, which 
also reduced the blood sugar.  However, BMI of con-
trol group had a slight upward trend , but  have no promi-
nent difference(P>0.05). This further proved the telemedi-
cine management  is effective to metabolic control.
In addition, 412 patients were followed up, a small 
number of subjects were lost during the 2 years follow- up 
period, and ITT and PP analysis revealed similar results, 
consequently, drawing the conclusion that it was reliable. 
However, because the lost subjects in control group ex-
ceeded 15%, it was failure comparison in 3 years, but 
the lost subjects of Tel group was less than 5%. Further 
investigation on the cause of the loss during follow-up 
by phone-call showed that the four main reasons were 
referring to worse diabetes management, lower income, 
lower education level, and greater distance to the hospital; 
this population with poor sugar control was especially 
vulnerable to disengagement. West China is regarded as 
the poorest with the backward areas，subjects have less 
economic development as they live on low income for 
a longtime, with poor diabetes care and lower education 
level. These might be the major cause of loss of subjects 
during follow-up. Furthermore, these results suggested 
that it was important to note that increasing the telemed-
icine management coverage for more subjects received 
point-of-care diabetes education, self-management coach-
ing, and medication adjustment. Therefore, perfect diabe-
tes telemedicine management might optimize glycemic 
control and improve compliance leading to reduction of 
diabetes complications, decreased rates of hospitalization, 
and mortality.
5. Conclusions
In conclusion, diabetes telemedicine management inter-
vention can decrease blood sugar, blood pressure and 
blood lipid compared with usual care , and may still im-
prove compliance to reduce the loss during follow-up. 
Consequently, diabetes telemedicine may be a useful tool 
for managing diabetes mellitus.
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